Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...
MedPage Today on MSN
Aortic Stenosis Mortality Increased After Broad FDA Approval of TAVR
Delays in diagnosis, long waits for operations may explain trend ...
Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.
Edwards pushes CMS to expand Medicare TAVR coverage to asymptomatic patients, sparking controversy among physicians over ...
Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following ...
Edwards Lifesciences (NYSE:EW) is ending its planned acquisition of JenaValve. The company is redirecting the capital that ...
While doctors may recommend medications and lifestyle changes to support overall heart health, these approaches cannot stop ...
Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
Shasta Regional Medical Center is celebrating the beginning of American Heart Month by reminding the public of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results